-transparent.png){kind=logo}
5-Aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives were synthesized and tested for their in vitro antimycobacterial activity. The compounds showed an interesting activity against a strain of Mycobacterium tuberculosis and a human strain of M. tuberculosis H4.
Related Publications
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
December 2011,
Bioorganic & medicinal chemistry letters,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
December 2011,
Acta crystallographica. Section E, Structure reports online,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
March 2012,
Acta crystallographica. Section E, Structure reports online,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
September 2011,
Acta crystallographica. Section E, Structure reports online,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
July 2010,
Bioorganic & medicinal chemistry,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
January 2014,
EXCLI journal,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
January 1999,
Farmaco (Societa chimica italiana : 1989),
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
January 2015,
Molecules (Basel, Switzerland),
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
December 2011,
Acta crystallographica. Section E, Structure reports online,
M G Mamolo, and
D Zampieri, and
V Falagiani, and
L Vio, and
E Banfi
October 2019,
European journal of medicinal chemistry,
